President Donald Trump has signed an executive order facilitating research into using psychedelic drugs for treating PTSD and other mental health issues. This decision is welcomed by many, particularly military veterans. Former Energy Secretary Rick Perry and retired Navy SEAL Marcus Luttrell endorse these treatments. FDA Commissioner Dr. Marty Makary points to the potential for innovative therapy breakthroughs.

In a related development, former Netflix executive Kevin Baillie has taken legal action against the streaming company. According to The New York Post, Baillie claims Netflix terminated his employment after he revealed he had undergone medically supervised ketamine treatment for depression. Baillie held the position of vice president and head of creative at Eyeline Studios, earning approximately $1.1 million annually. Following his disclosure at a Netflix retreat, Baillie alleges his termination involved denial of severance pay.

“The ketamine therapy issue has factored into the termination,” Baillie’s lawyer noted in the lawsuit.

Baillie sought ketamine therapy in 2022 at a Santa Barbara clinic due to clinical depression following his mother’s death. The therapy was prescribed and conducted under medical oversight. He shared this experience during a company exercise meant to promote openness among employees, where a Netflix investigator later queried it as potential recreational drug use.

Netflix conducted an investigation into Baillie’s language use and alcohol consumption, as his performance review had cited concerns about profanity but did not demand its complete cessation. The investigation also mentioned a demonstration Baillie gave at the retreat involving a Guinness beer trick, adhering to the session’s openness theme.

Netflix’s cultural ethos prioritizes vulnerability, candor, and rigorous performance assessments. Consistent feedback is encouraged, and employment decisions are aligned with company standards, known as the “keeper test.” Employees are evaluated and expected to acknowledge and learn from mistakes. Netflix’s public response to Baillie’s allegations was pending as of Monday.

Baillie seeks various forms of legal redress, including a jury trial and damages for lost wages and emotional distress. He previously contributed to major film franchises, such as “Pirates of the Caribbean” and “Harry Potter.” Ketamine, a Schedule III controlled substance, requires medical supervision when prescribed for depression, although it is sanctioned by the FDA for anesthesia.

Breakthrough therapy designations by the FDA, like ketamine-derived Spravato for depression, reflect ongoing advances in mental health treatments.